Dr. Pincez's research laboratory aims to use clinical, genetic, and genomic tools to improve the understanding, stratification, and prognosis of autoimmune cytopenias and red blood cell disorders. The objective is to bring the benefits of these approaches to patients in order to adapt and personalize care. To that end, they use different DNA sequencing approaches to study the effect of rare and frequent constitutional variants as well as somatic variants (clonal hematopoiesis). They also use RNA sequencing and proteomics approaches, coupled with clinical data in an integrative approach.